Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alembic Pharmaceuticals
Alembic secures USFDA approval for Diltiazem Hydrochloride extended-release capsules
Approval covers 120 mg, 180 mg, and 240 mg formulations for the treatment of hypertension and chronic stable angina
Alembic Pharmaceuticals announces early participation in the PM’s internship scheme
The company offers 125 internships as part of a national initiative for young talent development
Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and…
The approved ANDA is therapeutically equivalent to the reference listed drug product, Lamictal XR Extended-Release Tablets, 200…
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets
Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder
Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg
Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms…
Alembic gains USFDA final approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg
Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg have an estimated market size of $ 21 million for twelve months ending June 2024…
Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Arranon Injection, 250 mg/50 mL (5…
Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at…
Inspection conducted from July 17-26, 2024, concludes affirming facility’s compliance with GMP standards
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg,…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolixin Tablets, 1 mg, 2.5 mg, 5mg,…